Clinical Trial Update: A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating a thyroid hormone receptor beta (THRβ) agonist alone and in combination with a semicarbazide sensitive amine oxidase (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• Semicarbazide sensitive amine oxidase (SSAO) inhibitor
• Thyroid hormone receptor beta (THRβ) agonist

Snippet

Sponsor: Eccogene | Conditions: Metabolic Dysfunction-associated Steatohepatitis | Phase 2 | Status: RECRUITING